Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 17/20 | 0.72 |
| ▸ | RXRA | P19793 | 16/20 | 0.72 |
| ▸ | RARG | P13631 | 15/20 | 0.72 |
| ▸ | RARA | P10276 | 10/20 | 0.72 |
| ▸ | RXRG | P48443 | 8/20 | 0.72 |
| ▸ | RXRB | P28702 | 7/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.52 |
| ▸ | GMNN | O75496 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7224258 | 1.00 | RARB (0.72) | RARBRXRARARGRARARXRG | |
| SCHEMBL10841202 | 0.93 | RARB (0.62) | RARBRXRARARGRARARXRG | |
| SCHEMBL10841205 | 0.93 | RARB (0.62) | RARBRXRARARGRARARXRG | |
| SCHEMBL10843504 | 0.92 | RXRA (0.68) | RARBRXRARARGRARARXRG | |
| SCHEMBL10843511 | 0.92 | RXRA (0.68) | RARBRXRARARGRARARXRG | |
| SCHEMBL10841232 | 0.91 | RXRA (0.67) | RARBRXRARARGRARARXRG | |
| SCHEMBL10841235 | 0.91 | RXRA (0.67) | RARBRXRARARGRARARXRG | |
| SCHEMBL10842522 | 0.91 | RARB (0.76) | RARBRXRARARGRARARXRG | |
| SCHEMBL10843123 | 0.91 | RARB (0.76) | RARBRXRARARGRARARXRG | |
| SCHEMBL7224023 | 0.90 | RARB (0.72) | RARBRXRARARGRARARXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6627652-B1 | Treatment of diseases or conditions of the type which are normally treated with retinoid-like compounds is disclosed, with pharmaceutical compositions containing an active compound which is a selective agonist of the RXR retinoid | ALLERGAN, INC. | 2003-09-30 | — | — | US | disclosed |
| US-6624188-B1 | Administered to treat or prevent one or more of the diseases and conditions selected from the group consisting of dermatoses, atherosclerosis and restenosis resulting from neointimal hyperproliferation, non-malignant and | ALLERGAN, INC. | 2003-09-23 | — | — | US | disclosed |
| EP-0688213-B1 | TREATMENT OF TUMORS WITH COMPOUNDS HAVING RXR RETINOID RECEPTOR AGONIST ACTIVITY | ALLERGAN INC (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-1159961-A2 | Treatment of tumors with compounds having RxR retinoid receptor agonist activity | ALLERGAN, INC. (US) | 2001-12-05 | — | — | EP | disclosed |
| EP-0909560-A2 | Treatment o tumors with compounds having RXR retinoid receptor agoinst activity | ALLERGAN, INC. (US) | 1999-04-21 | — | — | EP | disclosed |
| US-5455265-A | For mammals; skin disorders, cancer, inflammatory disease, cardiovascular diorders, autoimmune diseases and others | ALLERGAN, INC. (US) | 1995-10-03 | — | — | US | disclosed |
| US-5399586-A | Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity | ALLERGAN, INC. (US) | 1995-03-21 | — | — | US | disclosed |
| US-5324840-A | Skin disorders | ALLERGAN, INC. (US) | 1994-06-28 | — | — | US | disclosed |
| US-4578498-A | FOR SKIN DISORDERS; REDUCED TOXICITY | BASF AKTIENGESELLSCHAFT (DE) | 1986-03-25 | — | — | US | disclosed |